Results 141 to 150 of about 49,337 (197)

Dosimetric evaluation of systematic source position uncertainty along the source path and robust planning during MRI‐only cervical HDR brachytherapy

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 10, October 2026.
Abstract Background The knowledge of the dosimetric impact of systematic source position uncertainty and the use of a methodology for robust treatment planning against such uncertainty can help improve the quality of treatment plans, during MR‐only cervical brachytherapy treatment.
Amritpal Singh   +3 more
wiley   +1 more source

Wood‐Based Cellulose Nanocrystals as Reinforcement for Sustainable Concrete Composites

open access: yesAdvanced Sustainable Systems, Volume 10, Issue 10, October 2026.
Wood‐derived cellulose nanocrystals (WCNCs) serve as sustainable nano‐reinforcements in normal‐strength concrete. Incorporation of an optimal WCNC dosage of 0.05 wt.% enhances the balance between workability and strength, resulting in significant increases in compressive strength (16.1%), splitting tensile strength (13.6%), and flexural load capacity ...
Ravi Patel   +2 more
wiley   +1 more source

Automated mRNA‐Based Detection of ER, PR, HER2, and Ki‐67 in Breast Cancer Tissue and Cytology Samples in Resource‐Limited Settings

open access: yesCancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Accurate detection of estrogen and progesterone receptors (ER/PR), HER2, and Ki‐67 is essential for molecular classification of breast cancer and in deciding upon tailored treatment. In many low‐ and middle‐income countries (LMICs), access to histopathology and immunohistochemistry (IHC) is limited.
Partha Basu   +15 more
wiley   +1 more source

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis

open access: yesCancer, Volume 132, Issue 19, 1 October 2026.
Abstract Background Ciltacabtagene autoleucel (cilta‐cel), an anti–B‐cell maturation antigen (BCMA) chimeric antigen receptor T‐cell (CAR‐T) therapy, is approved for relapsed/refractory multiple myeloma (RRMM). Methods Using the Center for International Blood and Marrow Transplant Research registry, this study evaluated outcomes of frail patients ...
Hira Mian   +31 more
wiley   +1 more source

Cross‐Sectional Associations Between Gut Microbiota and Neuroimaging Changes in Post‐COVID‐19 Condition

open access: yesComprehensive Physiology, Volume 16, Issue 5, October 2026.
In patients with post‐COVID‐19 condition, a significant shift in gut microbiota composition can be observed, marked by a decrease in butyrate‐producing taxa. Relevant taxa correlate with clinical symptoms, structural and functional brain changes, which suggests potential therapeutic targets and highlight the need for further investigation in their ...
Sophie Wetz   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy